coagulation abnormal
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged = 18 years old; 2) patients who underwent hip and knee replacement in our department from August 1, 2016 to December 31, 2017;
Exclusion criteria
Exclusion criteria: 1. The patients had not undergone TEG evaluation; 2. previous history of DVT or PE; 3. Patients treated with thromboprophylactic agents other than Rivaroxaban (including heparin, enoxaparin, aspirin warfarin, inferior vena cava filters, or any combination of VTE prophylactic drugs); 4. Patients did not treated with tranexamic acid; 5. The patients had thrombocytopenia, diagnosed hemophilia or chronic bleeding problems (eg, peptic ulcer), or decreased liver function; 6. Pre-operative anemia (hemoglobin <110 g/L in females and hemoglobin <12o g/L in males); 7. incomplete medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| thrombelastography; | — |
Countries
China
Contacts
The First Affiliated Hospital of Chongqing Medical University